| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.03M | - | |
| VP | 141.5K | $11.32M | - | |
| Other | 87.3K | $6.98M | - | |
| VP | 73.6K | $5.89M | -15,000 | |
| CFO | 70.1K | $5.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $43.11 | $431,065.00 | -2.4% | +17.1% | -14.2% | |
| May 12, 2022 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 13,987 | $37.54 | $525,074.78 | -7.7% | +37.5% | -1.9% | |
| May 4, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $39.43 | $394,321.00 | -2.4% | +3.3% | -4.2% | |
| Apr 20, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $37.89 | $378,867.00 | -2.4% | +5.7% | -3.2% | |
| Apr 7, 2022 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 23,148 | $42.58 | $985,755.27 | -12.1% | +2.2% | -15.7% | |
| Apr 5, 2022 | Jaw Ching47 | SVP Finance &CFO | Sale+OE | 25,000 | $40.80 | $1,020,000.00 | -15.7% | +8.8% | -10.4% | |
| Apr 4, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $38.78 | $387,834.00 | -2.4% | +9.6% | -9.3% | |
| Mar 21, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $36.03 | $360,342.00 | -2.4% | +21.1% | +1.7% | |
| Mar 15, 2022 | Schlossberg Mark A | SVP - Legal &General Counsel | Sale+OE | 25,196 | $33.96 | $855,724.19 | -19.6% | +15.8% | +9.8% | |
| Mar 10, 2022 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 26,852 | $37.82 | $1,015,462.08 | -13.8% | +10.1% | -6.0% |